Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
01 Pubblicazione su rivista
Locatelli F., Zugmaier G., Mergen N., Bader P., Jeha S., Schlegel P. -G., Bourquin J. -P., Handgretinger R., Brethon B., Rossig C., Chen-Santel C.
ISSN: 2044-5385
.